Inhibin A, B and pro-αC in serum and peritoneal fluid in postmenopausal patients with ovarian tumors

European Journal of Endocrinology

Volumn 142, Issue 4, 2000, Pages 334-339

  Ala Fossi, Sirkka Liisa ^a   Mäenpää, Juhani ^a   Bläuer, Merja ^b   Tuohimaa, Pentti ^b   Punnonen, Reijo ^a,b  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CA 125 ANTIGEN; FOLLITROPIN; INHIBIN A; INHIBIN B; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CANCER GRADING; CANCER STAGING; CLEAR CELL CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTADENOMA; ENDOMETRIOID CARCINOMA; FEMALE; FIBROMA; HUMAN; HUMAN CELL; HUMAN TISSUE; OVARY TERATOMA; OVARY TUMOR; PERITONEAL FLUID; POSTMENOPAUSE; PRIORITY JOURNAL; TUMOR DIFFERENTIATION; UNDIFFERENTIATED CARCINOMA;

EID: 0343238457     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1420334     Document Type: Article

References (29)

1. Helzlsouer KJ, Alberg AJ, Gordon GB, Longcope C, Bush TL, Hoffman SC et al. Serum gonadotropins and steroid hormones and the development of ovarian cancer. Journal of the American Medical Association 1995 274 1926-1930.
2. Burger HG. Inhibin. Reproductive Medicine Review 1992 1 1-20.
3. Burger HG & Fuller PJ. The inhibin/activin family and ovarian cancer. Trends in Endocrinology and Metabolism 1996 7 197-202.
4. Wallace EM. Inhibins: new tumour markers in gynaecology. Tumour Marker Update 1996 8 105-110.
5. Burger HG, Robertson DM, Cahir N, Mamers P, Healy DL, Jobling T et al. Characterization of inhibin immunoreactivity in postmenopausal women with ovarian tumours. Clinical Endocrinology 1996 44 413-418.
6. Burger HG. Inhibin as a tumour marker. Clinical Endocrinology 1994 41 151-153.
7. Petraglia F. Inhibin, activin and follistatin in the human placenta - a new family of regulatory proteins. Placenta 1997 18 3-8.
8. Zheng W, Luo MP, Welt C, Lambert-Messerlian G, Sung JC, Zhang Z et al. Imbalanced expression of inhibin and activin subunits in primary epithelial ovarian cancer. Gynecologic Oncology 1998 69 23-31.
9. Petraglia F, Florio P, Luisi S, Gallo R, Gadducci, Vigano P et al. Expression and secretion of inhibin and activin in normal and neoplastic uterine tissues. High levels of serum activin A in women with endometrial and cervical carcinoma. Journal of Clinical Endocrinology and Metabolism 1998 83 1194-1200.
10. Lappöhn RE, Burger HG, Bouma J, Bangah M, Krans M & de Bruijn HW. Inhibin as a marker for granulosa-cell tumors. New England Journal of Medicine 1989 321 790-793.
11. Healy DL, Burger HG, Mamers P, Jobling T, Bangah M, Quinn M et al. Elevated serum inhibin concentrations in postmenopausal women with ovarian tumors. New England Journal of Medicine 1993 329 1539-1542.
12. Cooke I, O'Brien M, Charnock FM, Groome N & Ganesan TS. Inhibin as a marker for ovarian cancer. British Journal of Cancer 1995 71 1046-1050.
13. Lambert-Messerlian GM, Steinhoff M, Zheng W, Canick JA, Gajewski WH, Seifer DB et al. Multiple immunoreactive inhibin proteins in serum from postmenopausal women with epithelial ovarian cancer. Gynecologic Oncology 1997 65 512-516.
14. Burger HG, Baille A, Drummond AE, Healy DL, Jobling T, Mamers P et al. Inhibin and ovarian cancer. Journal of Reproductive Immunology 1998 39 77-87.
15. Groome NP, Illingworth PJ, O'Brien M, Pai R, Rodger FE, Mather JP et al. Measurement of dimeric inhibin B throughout the human menstrual cycle. Journal of Clinical Endocrinology and Metabolism 1996 81 1401-1405.
16. Klein NA, Illingworth PJ, Groome NP, McNeilly AS, Battaglia DE & Soules MR. Decreased inhibin B secretion in older, ovulatory women: a study of serum and follicular fluid levels of dimeric inhibin A and B in spontaneous menstrual cycles. Journal of Clinical Endocrinology and Metabolism 1996 81 2742-2745.
17. Ala-Fossi S-L, Mäenpää J, Bläuer M, Aine R, Tuohimaa P & Punnonen R. Inhibin A and B in peri- and postmenopause. Maturitas 1998 30 273-281.
18. Groome NP, Illingworth PJ, O'Brien M, Priddle J, Weaver K & McNeilly AS. Quantification of inhibin pro-αC-containing forms in human serum by a new ultrasensitive two-site enzyme-linked immunosorbent assay. Journal of Clinical Endocrinology and Metabolism 1995 80 2926-2932.
19. Florio P, Luisi S, Vigano P, Busacca M, Fadalti M, Genazzani AR et al. Healthy women and patients with endometriosis show high concentrations of inhibin A, inhibin B, and activin A in peritoneal fluid throughout the menstrual cycle. Human Reproduction 1998 13 2606-2611.
20. Groome NP, Illingworth PJ, O'Brien M, Pai R, Rodger FE, Mather JP et al. Measurement of dimeric inhibin B throughout the human menstrual cycle. Journal of Clinical Endocrinology and Metabolism 1996 81 1401-1405.
21. Frias A, Li H, Keeney G, Podratz K & Woodruff T. Preoperative serum level of inhibin A is an independent prognostic factor for the survival of postmenopausal women with epithelial ovarian carcinoma. Cancer 1999 85 465-471.
22. Voutilainen R, Erämaa M & Ritvos O. Hormonally regulated inhibin gene expression in human and adult adrenals. Journal of Clinical Endocrinology and Metabolism 1991 75 1026-1030.
23. Roberts VJ, Barth S, El-Roeiy A & Yen SSC. Expression of inhibin/activin subunits and follistatin ribonucleic-acids and proteins in ovarian follicles and the corpus luteum during the human menstrual cycle. Journal of Clinical Endocrinology and Metabolism 1993 77 1402-1410.
24. Anderson RA, Groome NP & Baird T. Inhibin A and inhibin B in women with polycystic ovarian syndrome during treatment with FSH to induce mono-ovulation. Clinical Endocrinology 1998 48 577-584.
25. Petraglia F, Luisi S, Pautier P, Sabourin J-C, Rey R, Lhomme C et al. Inhibin B is the major form of inhibin/activin family secreted by granulosa cell tumors. Journal of Clinical Endocrinology and Metabolism 1998 83 1029-1032.
26. Robertson DM, Cahir N, Burger H, Mamers P, McCloud P, Petterssom K et al. Combined inhibin and CA 125 assays in the detection of ovarian cancer. Clinical Chemistry 1999 45 651-658.
27. Hemmings R, Falcone T, Billiar R & Tulandi T. Peritoneal fluid inhibin during the menstrual cycle. Obstetrics and Gynecology 1992 80 27-29.
28. Billiar RB, Hemmings R, Smith P & Groome N. Identification of biologically active inhibin in the peritoneal fluid of women. Journal of Assisted Reproduction and Genetics 1995 12 55-60.
29. Matzuk MM, Finegold MJ, Su JE, Hsueh AJ, Bradley A et al. Alpha-inhibin is a tumour-suppressor gene with gonadal specificity in mice. Nature 1992 360 313-319.